Tenet Healthcare (NYSE:THC) Announces Quarterly Earnings Results, Beats Estimates By $1.25 EPS

Tenet Healthcare (NYSE:THC - Get Free Report) released its earnings results on Tuesday. The company reported $4.36 EPS for the quarter, topping analysts' consensus estimates of $3.11 by $1.25, Zacks reports. The firm had revenue of $5.22 billion during the quarter, compared to analyst estimates of $5.15 billion. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. The business's quarterly revenue was down 2.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.22 EPS. Tenet Healthcare updated its FY 2025 guidance to 11.990-13.120 EPS.

Tenet Healthcare Price Performance

Shares of THC traded up $9.75 during midday trading on Tuesday, hitting $133.66. The company's stock had a trading volume of 1,147,738 shares, compared to its average volume of 1,511,647. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. Tenet Healthcare has a one year low of $104.06 and a one year high of $171.20. The stock has a market capitalization of $12.61 billion, a price-to-earnings ratio of 4.15, a price-to-earnings-growth ratio of 1.02 and a beta of 1.77. The company's fifty day simple moving average is $126.27 and its two-hundred day simple moving average is $136.57.

Analysts Set New Price Targets

A number of brokerages recently weighed in on THC. Barclays cut their price target on shares of Tenet Healthcare from $190.00 to $161.00 and set an "overweight" rating on the stock in a research report on Thursday, February 13th. Morgan Stanley initiated coverage on Tenet Healthcare in a research note on Wednesday, March 26th. They issued an "overweight" rating and a $165.00 target price for the company. Guggenheim initiated coverage on Tenet Healthcare in a research note on Wednesday, April 9th. They set a "buy" rating and a $165.00 target price for the company. KeyCorp lowered their price objective on shares of Tenet Healthcare from $200.00 to $185.00 and set an "overweight" rating for the company in a research report on Tuesday, January 7th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $177.00 target price on shares of Tenet Healthcare in a research note on Thursday, February 13th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $165.44.

Insider Activity at Tenet Healthcare

In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the firm's stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the sale, the director now owns 27,378 shares in the company, valued at $3,434,022.54. This trade represents a 25.81 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.81% of the stock is currently owned by insiders.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.